Skip to main content

1-20 of 1,594 results for subject:Misuse

Subject X
Medical treatments

Type

House

Session

Year

Department

More

Member

More

Primary member

More

Answering member

More

Legislative stage

Legislation

Subject

More
Medical treatments (1,594)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

In 2024, 76% of adults in England said that they drink alcohol. 21% of adults drank more than the recommended weekly limit of 14 units of alcohol.

Type
Commons Briefing papers
Date
13 May 2026
Reference
CBP-7626

To ask His Majesty's Government what assessment they have made of the role of digital technologies in supporting treatment and recovery services for people experiencing drug and alcohol addiction.

Asked by
Lord Taylor of Warwick (Non-affiliated)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
1 April 2026
Reference
HL15512
House
House of Lords

To ask the Secretary of State for Health and Social Care, if his Department will review the Mental Health Act 1983 to ensure people with co-occurring mental health and substance misuse needs are not excluded from treatment.

Asked by
Tom Hayes (Labour)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
12 January 2026
Reference
102244
House
House of Commons

To ask the Secretary of State for Health and Social Care, whether he has made an assessment with the Home Secretary of the potential merits of funding a wider rollout of long-acting Injectable Buprenorphine as a treatment option for people using opioids in Dorset.

Asked by
Vikki Slade (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
11 November 2025
Reference
87603
House
House of Commons

A Commons debate on obesity and fatty liver disease will take place on Tuesday 28 October 2025. The debate will be opened by Dr Beccy Cooper. The Library will publish a briefing ahead of the debate.

Type
Commons Debate packs
Date
24 October 2025
Reference
CDP-2025-0197

On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.

Type
Commons Debate packs
Date
7 July 2025
Reference
CDP-2025-0157

The Controlled Drugs (Procedure for Specification) Bill 2024-2025 had its second reading on Friday 7 March 2025. It was considered by a Public Bill Committee on 25 June 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.

Type
Briefing papers on bills
Date
4 July 2025
Reference
CBP-10286

A debate has been scheduled in Westminster Hall at 1.30pm on 27 March on prevention of drugs deaths. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.

Type
Commons Debate packs
Date
26 March 2025
Reference
CDP-2025-0071
Type
Select Committee written evidence; Parliamentary committees
Committee
Committee of Public Accounts
Date
3 March 2025
House
House of Commons

Current UK legislation to control drugs, the enforcement of drug laws and calls for reform to the classification of drugs in the UK.

Type
Commons Briefing papers
Date
2 December 2024
Reference
CBP-10154

Motion that the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved. Agreed to on question.

Lead member
Karin Smyth
Answering member
Ben Spencer
Department
Department of Health and Social Care
Type
Debates on delegated legislation
Date
9 September 2024
Reference
753 cc649-673
House
House of Commons

It is not often that one speaks in this place on changes to the law that will have the direct result of saving lives, but once the draft regulations pass, as I hope they will this evening, we expect them to save many peoples’ lives. Today is a very special...

Member
Ben Spencer (Conservative)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 cc652-3
House
House of Commons

It is good to a hear consensus building across the House on naloxone because, as we have heard from other Members, it is a lifesaver. Since its roll-out in the UK, that highly effective antidote to opioid intoxication has doubtlessly saved hundreds of lives and prevented many more harmful overdoses,...

Member
Bobby Dean (Liberal Democrat)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 cc653-4
House
House of Commons

I thank all those who have made maiden speeches and valuable contributions today. As the Democratic Unionist party’s health spokesperson, it is important that I speak on this issue to provide, as I always do, a Northern Ireland perspective for the Minister, the shadow Minister and all others who have...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 cc654-6
House
House of Commons

Alongside hon. Members who have spoken on behalf of other parties, I welcome the changes. Naloxone saves lives: it brings people back from one of the most final and, in many cases, fatal mistakes they can make.

This is a really important change to make, but I hope that the regulations...

Member
Siân Berry (Green Party)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 c656
House
House of Commons

I thank the Minister for bringing this statutory instrument to the House. As I think all hon. Members have said, naloxone has proven itself time and again to be the lifesaving

drug that reverses the effect of a devastating opioid overdose. That is especially important because opioid-related deaths now make...

Member
Robin Swann (Ulster Unionist Party)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 cc656-7
House
House of Commons

In my contribution I asked a question—which the hon. Member for South Antrim (Robin Swann) has reminded me of—about ensuring that medical staff who have the expertise to administer naloxone, but do so outside of their job, are covered and that there is no comeback against them. Could the Minister...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 c658
House
House of Commons

I beg to move,

That the draft Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, which were laid before this House on 29 July, be approved.

I, too, congratulate you on your election, Madam Deputy Speaker; it really is a pleasure to see you in the Chair.

The draft...

Member
Karin Smyth (Labour)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 cc650-1
House
House of Commons

This evening, I am standing in for my hon. Friend the public health Minister, who could not be here. I might offer to stand in again, such has been the rare outbreak of unanimity across this House. I know from my own experience in the sector that that is often...

Member
Karin Smyth (Labour)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 cc657-8
House
House of Commons

I understand that there are some concerns about that issue, and we will make sure that the hon. Member receives a full answer from my hon. Friend the public health Minister.

In short, these changes will widen access to life-saving medicine. I am sure hon. Members will agree that any death...

Member
Karin Smyth (Labour)
Type
Proceeding contributions
Date
9 September 2024
Reference
753 c658
House
House of Commons